Preoperative Blood Pressure Strategies Yield Similar Postoperative Cognitive Results
By Elana Gotkine HealthDay Reporter
FRIDAY, June 6, 2025 -- For patients undergoing noncardiac surgery, neurocognitive outcomes do not differ with hypotension-avoidance and hypertension-avoidance strategies, according to a study published online June 3 in the Annals of Internal Medicine.
Maura Marcucci, M.D., from Population Health Research Institute in Hamilton, Ontario, Canada, and colleagues compared the effects of perioperative hypotension-avoidance versus hypertension-avoidance strategies on delirium and cognitive decline after noncardiac surgery in a study involving 2,603 high vascular-risk patients receiving one or more chronic antihypertensive medications. The intraoperative mean arterial pressure (MAP) target was 80 mm Hg or greater in the hypotension-avoidance strategy group compared with 60 mm Hg or greater in the hypertension-avoidance strategy group (1,301 and 1,293 patients, respectively).
The researchers found that 7.3 and 7.0 percent of patients in the hypotension-avoidance and hypertension-avoidance groups had delirium on postoperative days 1 to 3, respectively (relative risk, 1.04; 95 percent confidence interval, 0.79 to 1.38). Among 701 patients who completed the Montreal Cognitive Assessment one year after surgery, 37.2 and 33.1 percent in the hypotension-avoidance and hypertension-avoidance groups had a decline of 2 or more points, respectively (relative risk, 1.13; 95 percent confidence interval, 0.92 to 1.38). Hypotension requiring an intervention occurred in 19 and 27 percent of patients in the hypotension-avoidance and hypertension-avoidance groups, respectively (relative risk, 0.63; 95 percent confidence interval, 0.52 to 0.76), mostly intraoperatively; in both groups, only 5 percent had hypotension postoperatively.
"Our findings do not support targeting an intraoperative MAP of 80 mm Hg or greater, compared with a MAP of 60 mm Hg or greater," the authors write.
Several authors disclosed ties to the medical technology or pharmaceutical industries.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted June 2025
Read this next
Salt Substitutes Infrequently Used by U.S. Adults
FRIDAY, Sept. 5, 2025 -- Few U.S. adults use salt substitutes (SS), including those with hypertension, according to a study presented at the American Heart Association...
Mortality Rates From Hypertensive Renal Disease Increased From 1999 to 2023
FRIDAY, Sept. 5, 2025 -- From 1999 to 2023, there was an increase in age-adjusted mortality rates (AAMRs) for hypertensive renal disease, according to a study presented at the...
Sense of Life Purpose Lowers Risk for Cognitive Impairment
THURSDAY, Sept. 4, 2025 -- A sense of purpose in life (PiL) is associated with a lower risk for and later onset of cognitive impairment, according to a study published online in...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.